Episode Synopsis "Targeted treatment: How an Australian research team is using omics and large datasets for VTE risk prediction"

Australia’s James McFadyen and Hannah Stevens join the podcast to reveal their latest research on immunothrombosis and monoclonal antibody therapies. They are developing novel platelet targeted therapies for the treatment of thrombosis and immunothrombosis, and recently their team is using omics and large datasets for VTE risk prediction. Learn the full scope of their research, from utilizing AI in their work, to how the research results will help improve thrombosis treatment in the future.

Listen "Targeted treatment: How an Australian research team is using omics and large datasets for VTE risk prediction"

More episodes of the podcast ISTH Podcasts

• Targeted treatment: How an Australian research team is using omics and large datasets for VTE risk prediction
• Brooke Sadler on her journey to hematology: Family roots, mentorship and a passion for pediatrics
• A Sneak Peek Into #ISTH2025 in Washington, D.C., with Congress Chair Guy Young
• Early Career Chronicles: Mentorship, Science, and Fun Facts with Thita Joy Chiasakul
• Silent burden: Unveiling the overlooked psychological impact of VTE
• Breaking down the ISTH Hemophilia Guidelines: Essential information you need to know
• From Paper to Passion: How Omid Seidizadeh Began his Career in von Willebrand Factor Research
• Webinar Preview: New Insights in Diagnosis and Treatment of Antiphospholipid Syndrome
• Congress Daily News Series, Episode 6: ISTH 2025 Congress in Washington D.C.!
• Congress Daily News Series, Episode 5: Journal Editors Share their Vision for JTH and RPTH
• Congress Daily News Series, Episode 4: Register Now for Educational Workshop Hosted in Croatia
• Congress Daily News Series, Episode 3: Guideline for Hemophilia Treatment
• Congress Daily News Series, Episode 2: ISTH DEI Committee Spotlight
• Congress Daily News Series, Episode 1: ISTH Trivia
• South America Episode 1 Prevalence Outcomes And Diagnostic Challenges for Patients with TTP
• South America Episode 2 Current And Recent Advances In Treatments for Patients with TTP
• Asia-Pacific Episode 1 Prevalence Outcomes and Diagnostic Challenges for Patients with TTP
• Asia-Pacific Episode 2 Current and Recent Advances in Treatments for Patients with TTP
• Middle East Episode 2 Current and Recent Advances In Treatments for Patients with TTP
• Middle East Episode 1 Prevalence Outcomes and Diagnostic Challenges for Patients with TTP
• When to Suspect TTP and What to Do About it
• What’s on the Horizon for TTP Research and Treatment
• TTP Registries - Opportunities and Challenges